39 results
6-K
EX-99.1
BWAY
Brainsway Ltd
17 Apr 24
Company Announces 11th Recent System Installed in Israel, with More Expected this Year
8:00am
important to us that Deep TMS be made available to as many patients as possible,” concluded Mr. Levy.
"This innovative technology represents a significant
6-K
EX-99.1
BWAY
Brainsway Ltd
4 Apr 24
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
8:00am
Affairs at BrainsWay. “The two-stage H-Coil protocol is an innovative approach to address multiple symptoms of the disease. While further research
6-K
EX-99.1
BWAY
Brainsway Ltd
6 Mar 24
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
7:30am
of $31.8 million represented an increase of 17% over full-year 2022, reflecting the strong and growing demand for our innovative Deep TMS technology,” said … market all continue to position BrainsWay as the leading innovative force in the TMS industry,” concluded Mr. Levy.
Conference Call and Webcast
6-K
EX-99.1
BWAY
Brainsway Ltd
10 Jan 24
Current report (foreign)
7:30am
treatments for mental health disorders, today announced that it will be clinically evaluating an innovative stimulation technology in two new feasibility
6-K
EX-99.1
xseln242c7a0f4
15 Nov 23
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
7:30am
6-K
EX-99.1
2t5f2bpuatldo262ik
16 Oct 23
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression
7:30am
6-K
EX-99.1
pr8f81v7y ovyp
5 Sep 23
10 Deep TMS™ Systems to be Installed in 2023 Alone
7:30am
6-K
EX-99.1
173rejsf ck
23 May 23
BrainsWay Announces Appointment of Ido Marom as CFO
7:30am
6-K
EX-99.1
2vk1lo1ovt9equls5t
16 Nov 22
BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
EX-99.1
kd0bftxypzevo81u
9 Mar 22
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights
7:30am
6-K
EX-99.1
st0 z0riiyg8
31 Jan 22
Current report (foreign)
7:30am
6-K
EX-99.1
wjy748gh
17 Nov 21
Current report (foreign)
4:01pm
F-3
rtvp1h7xo
17 Sep 21
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
l5z5p41
1 Jun 21
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
8:00am
6-K
EX-99.1
dz0gpuhvqqg2gr
5 May 21
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
8:00am
SC TO-I
EX-99
u565z9hlnsk10qze
4 May 21
Issuer tender offer statement
9:28am
424B5
vvp94
24 Feb 21
Prospectus supplement for primary offering
4:31pm